Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.35
-9.80 (-1.06%) Natco Pharma informs about press release
Date: 14-06-2021Natco Pharma has informed that it has enclosed the Press Release on 14th June 2021 titled ‘NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS®) in the US market’.
The above information is a part of company’s filings submitted to BSE.